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Abstract
Bacterial urinary tract infections (UTI) are a major growing concern worldwide. Uropathogenic Escherichia coli has
been shown to invade the urothelium during acute UTI in mice and humans, forming intracellular reservoirs that can
evade antibiotics and the immune response, allowing recurrence at a later date. Other bacterial species, such as
Staphylococcus saprophyticus, Klebsiella pneumonia and Salmonella enterica have also been shown to be invasive
in acute UTI. However, the role of intracellular infection in chronic UTI causing more subtle lower urinary tract
symptoms (LUTS), a particular problem in the elderly population, is poorly understood. Moreover, the species of
bacteria involved remains largely unknown. A previous study of a large cohort of non-acute LUTS patients found that
Enterococcus faecalis was frequently found in urine specimens. E. faecalis accounts for a significant proportion of
chronic bladder infections worldwide, although the invasive lifestyle of this uropathogen has yet to be reported. Here,
we wanted to explore this question in more detail. We harvested urothelial cells shed in response to inflammation
and, using advanced imaging techniques, inspected them for signs of bacterial pathology and invasion. We found
strong evidence of intracellular E. faecalis harboured within urothelial cells shed from the bladder of LUTS patients.
Furthermore, using a culture model system, these patient-isolated strains of E. faecalis were able to invade a
transitional carcinoma cell line. In contrast, we found no evidence of cellular invasion by E. coli in the patient cells or
the culture model system. Our data show that E. faecalis is highly competent to invade in this context; therefore,
these results have implications for both the diagnosis and treatment of chronic LUTS.
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Introduction
Urinary tract infection (UTI) is a significant cause of
morbidity, ranking as one of the most prevalent infectious
diseases worldwide [1,2]. By the age of 24, nearly one third of
women will have sought medical attention for an acute, self-
limiting UTI and between 15-25% of this group will suffer from a
recurrent or chronic form of this disease [2–5]. Acute UTI is not
diagnostically challenging [6], as the rapid onset of urinary
frequency and dysuria are clear indicators of the pathology.
Less clear cut are lower urinary tract symptoms (LUTS), a
collective term describing a host of urological manifestations,
including symptoms of urine storage and voiding, and pain
attributed to the lower urinary tract [7]. While the role of
infection in the generation of acute symptoms is well
recognised, an infective aetiology in other LUTS is not typically
assumed. In fact, most current guidance on the management of
LUTS calls for the exclusion of UTI using routine urinalysis
methods [8,9]. In this context, the term LUTS had become
synonymous with non-infectious disease. The clinical features
of UTI and LUTS show considerable overlap, however, and the
prevalence of both disorders rises dramatically with age
[10–13].
Our research centre and others have found that the tests
deployed to screen for UTI are largely inadequate, particularly
in patients who do not present with classic acute infective
symptoms [14–16]. Although LUTS can undoubtedly be caused
by other factors (e.g. carcinoma, urethral stricture, prostatic
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disease, bladder stones or affective disorders such as those
common in multiple sclerosis [17,18]), we now know that
patients scoring as negative on routine tests for infection might
in fact harbour a low-grade bacterial pathology [19].
By far the most prevalent bacterial species implicated in
acute UTI is E. coli, which is responsible for as many as to 90%
of diagnosed cases of nosocomial and community-acquired
bladder infection [20]. Murine models of acute UTI have shown
that uropathogenic E. coli (UPEC) invades and forms
intracellular bacterial communities (IBCs) in the bladder where
it is able to evade immune surveillance and a number of
systemic antibiotic treatments [5,21–27]. The findings from
these studies have resulted in a well-accepted model of the
acute UTI UPEC life cycle [25]. Adhesion and invasion into the
host cell cytoplasm are closely followed by three distinct stages
of the intracellular bacterial community (IBC) lifecycle. During
early IBC, loose collections of bacillus bacteria rapidly divide
inside the cytoplasm proper. In middle IBC, daughter cells
exhibiting a coccoid morphology pack tightly producing a
biofilm-like pod [23]. At the late IBC stage, bacteria at the
periphery of the intracellular biofilms regain a rod morphology
and become highly motile, leading to bacterial efflux and re-
infection of adjacent cells [25].
Infected umbrella cells will be shed from the epithelial lining
into the urine. Such sloughing is known in both mice and
humans to be a common response to infection [24,28–31]. This
dramatic cell shedding response leaves a gap in the epithelial
layer, exposing naive transitional cells (proximal to the
submucosal coat) to de novo UPEC invasion, a process which
has been proposed to create quiescent intracellular reservoirs
(QIR) responsible for latent recurrent and low-level chronic
infection in mice [5,22,26,31,32]. Although QIR have not been
directly observed in human patients, there is much evidence to
suggest their existence [5,22,26,31,33–35]. Other IBC stages
above, namely bacterial filamentation, have also been
described in acute human UTI [24], although murine models
remain more thoroughly studied.
Given the prevalence of UPEC as a causative agent in UTI,
UPEC remains the most widely studied uropathogen. It is now
recognized, however, that urothelial invasion may not be
restricted to E. coli alone, with Staphylococcus saprophyticus
[36] and Klebsiella pneumonia [37] also exhibiting UPEC-like
intracellular lifestyles in experimental murine acute UTI.
Recently, we explored an infective aetiology in LUTS using a
traditional gentamicin protection assay, in which shielded
bacteria were enumerated after extracellular bacteria were
killed off by antibiotics [19]. In this study, Enterococcus
faecalis, Streptococcus anginosus, E. coli, and Proteus
mirabilis were shown to be closely associated with the shed
cells. Although this assay is a trusted and well-tested method
for detecting intracellular bacteria [38,39], the information
gleaned from this technique is indirect. Furthermore, antibiotic-
susceptible E. faecalis readily forms heavily antibiotic-resistant
biofilms which could be responsible for false-positive outputs
[40,41].
In the LUTS study described above, E. faecalis was the most
cell-associated pathogen described, much more so than E. coli.
In addition, E. faecalis is frequently isolated in acute UTI
[10,24] and non-dysuric LUTS patients [19], and is commonly
implicated in catheter-associated and chronic urinary tract
infection [42,43]. In the past few years Enterococcus spp. have
received a significant amount of attention. This opportunistic
uropathogen is of particular concern in the clinical setting,
where multi-drug resistant strains are frequently involved in
hospital-acquired infection. Moreover, the rapid acquisition of
antibiotic resistance, biofilm formation [40,41] and the innate
ability to thrive and persist in the urinary tract make UTIs
caused by Enterococcus spp. particularly difficult to eradicate
[42,44–47]. Despite its commonness in bladder infections,
aside from our recent paper [19], there have been no reports of
E. faecalis associated with patient urothelial cells, nor any
description of its potential intracellular invasion more direct
than the antibiotic protection assay. We therefore set out to
explore the role of cell shedding and bacterial invasion in LUTS
in more detail.
Results
Significant urothelial shedding in the LUTS bladder
In order to study the role of infection and inflammation in
LUTS, and to determine whether shed epithelial cells could be
used as a further means of studying intracellular infection in
more detail, we recruited 705 patients presenting at first visit to
the clinic, 606 females and 99 males with a mean age of 51
years (sd=17.5). Of the 705 urine samples, 522 (74%) were
found to be negative on routine mid-stream urine (MSU) culture
(using a culture positive threshold of ≥ 105 cfu ml-1 of a single
known uropathogen) and 183 (26%) were positive. It should be
noted that this routine MSU culture threshold, while standard
for the UK and some other countries, misses significant
infection in our clinical experience. For main demographic data
and symptomatology please see Figure S1.
Pyuria (white blood cells [WBC] µl-1), quantified immediately
in fresh, unspun specimens of urine, is the best clinical
indicator of UTI currently available. The patients were
categorised into three groups according to pyuria expression:
(1) for zero pyuria; (2) for pyuria 1 to 9 WBC µl-1; and (3) for
pyuria ≥10 WBC µl-1. Pyuria ≥10 WBC µl-1 has long been
advocated as a diagnostic threshold to discriminate between
the presence or absence of lower urinary tract pathology. First
described by Dukes in 1928 [48], this diagnostic threshold does
not withstand contemporary scientific scrutiny [16], and there
are no published data demonstrating that pyuria of 1 to 9 WBC
µl-1 is non-pathological [49]. Indeed, 1-9 WBC µl-1 does predict
underlying disease [49], so we thought it prudent to include this
category.
In addition to WBC, mouse and human bladders shed
urothelial cells into the urine as part of an innate immune
response to bacterial insult in acute UTI [24,28–31]. Therefore,
we also counted epithelial cells (EPC µl-1) in the urine of LUTS
patients. First, we recognized the requirement for proof of
cellular origin as a proportion of these cells could be
contaminants originating from the genitalia and perineum.
Uroplakin-III (UP3) is expressed solely on the asymmetric unit
membrane of urothelial cells [50,51]. Therefore, we targeted
this glycoprotein using immunofluorescence to determine the
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proportion of urinary epithelial cells that originated in the
urinary tract (Figure 1A, B). A subset of 44 randomly selected
LUTS patients was included in this experiment. MSU samples
from 22 patients with chronic LUTS (F=22; mean age=51;
sd=19) were compared with vaginal swabs from 22 further
chronic LUTS patients (F=22; mean age=50; sd=20). The
median percentage of UP3-positive cells in the MSU samples
was 75% (Q1=68, Q3=78.5) but only 25% (Q1=19, Q3=32) in
the vaginal swabs (Figure 1C). The results of a Mann-Whitney
test show the proportion of UP3-positive cells found in the urine
of chronic LUTS patients to be significantly higher than that in
the vagina (U=1, p <.001). Therefore we could be confident
that our cell analyses were representative of underlying
pathology of the bladder.
We counted shed EPC in the 705 patient cohort (Figure 2A).
The EPC counts were positively skewed and log transformation
had a limited normalisation effect, changing the skewness from
13.4 to 0.63. We therefore compared the median log10 epithelial
cell count (log10 EPC µl-1) between categories, non-
parametrically. Figure 2A shows clear between group
differences between these categories (Kruskal-Wallis Χ2 = 75,
p<.001, df=2). Post hoc analysis using Mann-Whitney test
comparisons with a Bonferroni correction confirmed that all
three groups differed among one another (p<.001). A similar
comparison between the 522 (74%) showing a negative MSU
culture and the 183 (26%) that were positive showed no
between group differences (U=19x103, P=.5). Therefore, the
degree of EPC shedding corresponds to amount of pyuria, and
by association, severity of infection.
In summary, this evidence supports the murine model of
bacteria-induced urothelial inflammation and shedding in LUTS
patients. Given that infection seemed to correlate with
symptoms in this cohort, we set out to study the underlying
microbiology in closer detail.
Implicating intracellular E. faecalis bacterial infection in
the aetiopathology of LUTS
As with previous work exploring cellular invasion during
acute UTI in humans [24], we inspected shed urothelial cells
from LUTS patients with non-acute UTI for signs of bacterial
association and intracellular pathology. Prior to imaging, the
urine samples were cultured on chromogenic agar and any
arising bacteria identified using a rigorous series of biochemical
assays as outlined in the methods section.
For this experiment we studied a randomly selected subset
of 48 specimens using epi-fluorescent microscopy to identify
bacterial involvement. MSU samples were donated by 24
female LUTS patients (mean age=52; sd=10.7) and compared
with an equal number of samples from female healthy normal
controls (N=24; mean age=48; sd=9.9). Although these 24
LUTS patients were negative for routine MSU culture, growing
<105 cfu ml-1 of a single known uropathogen, 10 exhibited
growth of E. coli and/or E. faecalis with the addition of other
species. One of these samples exhibited growth of only E. coli
and E. faecalis with no other species present which gave us
the opportunity to compare how each bacterium behaved. This
sample was selected for confocal microscopy to explore
intracellular pathology.
Our previous work, which explored intracellular colonisation
of the LUTS bladder, presented data from antibiotic protection
assays alone [19]. This microbiological data is indirect and can
be misleading, as detergents may liberate live membrane-
bound bacteria. This technique is hindered further by the
presence of extracellular biofilms which may be unaffected by
even high concentrations of antibiotics. Therefore, to decisively
inspect these cells for intracellular colonisation we conducted
confocal laser-scanning microscopy in conjunction with a bank
of extensive 3D digital analyses.
On epi-fluorescent analysis, 75% (N=18) of the LUTS patient
samples showed evidence of infected urothelial cells in
comparison to only 17% (N=4) in the control group (Figure 2B).
Data from the confocal analysis of a representative sample
suggested that E. faecalis and E. coli employ distinct
pathological strategies in these patients, with only E. faecalis
exhibiting cellular invasion. Figure 3 shows two representative
cells shed from the bladder of a LUTS patient with a mixed
sub-threshold infection with E. faecalis and E. coli. Cells that
were associated with adherent extracellular bacilli (E. coli) did
not contain intracellular bacterial communities (Figure 3D).
However, in cells exhibiting adherent, extracellular coccoid E.
faecalis (Figure 3A, broken white arrow), we found compelling
evidence of intracellular pathology (Figure 3A, white arrow, B,
C). Although uropathogenic E. coli have the unusual ability to
transform from a rod to coccoid morphology within the
intracellular niche within the centre of a tightly packed IBC
[23,24], we saw isolated intracellular coccoid forms, too
dispersed to be coccoid E. coli, suggesting that the organism
was indeed E. faecalis.
LUTS patient-isolated E. coli does not invade cells in a
cell culture model system
So far, we have shown that the presence of LUTS is
associated with shedding of the urothelium, which is likely
activated by the presence of bacteria. The confocal data from
analysis of shed patient cells suggested that E. faecalis
employed an invasive lifestyle whereas E. coli was ubiquitously
extracellular.
Given the difficulty of identifying in advance patient cells that
harboured E. coli and/or E. faecalis in the absence of other
species, we decided to use defined infections in cell culture to
explore this issue further. We designed a cell culture system to
model the infection process using five strains of E. coli isolated
from routine MSU-culture negative LUTS patients. We infected
a T24 transitional bladder cell line before, as with the shed
urothelial cells, fluorescently staining and imaging using high-
resolution confocal microscopy. The invasive properties of
these strains were analysed using a series of 3D digital
analyses.
All of the five E. coli-infected T24 cells exhibited marked
bacterial adhesion and colonisation (See Figure 4A, D for a
representative example). Orthogonal views of Z-stack 3D
constructs, however, showed the colonies of each strain of
bacteria to be entirely extracellular (Figure 4B). Further
analysis using Z-axis profile plots supported these findings,
with the peak mean pixel intensity of the DAPI labelled bacteria
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Figure 1.  Uroplakin-3 (UP3) immunofluorescence.  (A) Confocal image of a UP3-positive urothelial cell shed into the urine of a
LUTS patient, a composite showing the expression of UP3 in red and DAPI-stained host (solid white arrow) and bacterial (broken
white arrow) DNA in blue. Each channel is also shown in monochrome. The boundary of the cell is represented by a broken white
line. White scale bar is 10µm. (B) Epi-fluorescent image of UP3-positive urothelial cells (solid white arrow) and a single UP3-
negative epithelial cell (broken white arrow) harvested from the urine of a patient with LUTS. The composite image shows UP3 in
red, host DNA in blue and the brightfield (BF) channel in greyscale. Channels are also shown separately in monochrome. White
scale bar is 50µm. (C) Graph showing the median proportion of UP3-positive cells found in MSU samples (N=22) when compared
with vaginal swabs (N=22). 75% (Q1=68, Q3=78.5) of the cells found in the MSU samples were UP3-positive in contrast to only
25% (Q1=19, Q3=32) in the vaginal swabs (U=1, p <.001).
doi: 10.1371/journal.pone.0083637.g001
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(blue) found to be some distance away (in the Z-axis) from that
of the phalloidin labelled F-actin (red) (Figure 4C).
Remarkably, it appeared that these LUTS-isolated strains of
E. coli formed tightly packed extracellular biofilms on the
surface of the T24 cells (Figure 4D). Positive staining with
wheat germ agglutinin (WGA) in a gram-negative organism like
E. coli signifies the secretion of an exopolymeric matrix,
inherent in biofilm formation [52] [53] (Figure 4A, white arrows).
LUTS patient-isolated E. faecalis invades cells in a cell
culture model system
Confocal analysis of shed LUTS patient urothelial cells
demonstrated cellular invasion by E. faecalis. To test further
whether E. faecalis is competent to invade urothelial cells, as
our earlier findings would suggest, we challenged the same
T24 bladder cell culture model system as described above with
five strains of E. faecalis isolated from routine MSU-culture
negative LUTS patients. Again, the infected cells were imaged
Figure 2.  Urinary epithelial cell counts and bacterial pathology.  (A) Relationship between the median log urinary epithelial
count (EPC=epithelial cell) and the level of pyuria observed in the urine of LUTS patients (WBC=white blood cell). The mean log
epithelial cell counts at each state of pyuria proved to be significantly different. (B) Bar chart showing the percentage of specimens
with bacteria-association urinary epithelial cells (EPC) in LUTS patients (75%) and healthy controls (17%). Representative images
of infected urinary EPC from LUTS patients (red) and normal EPC for healthy controls (blue) shown for reference. White scale bar is
10µm.
doi: 10.1371/journal.pone.0083637.g002
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Figure 3.  Bacterial invasion in shed urothelial cells.  Prior to imaging, the urine sample was cultured on chromogenic agar and
bacterial identities confirmed using a bank of biochemical assays as outlined in the methods section. By supporting the confocal
data with culture results and bacterial identity we were able recognize bacteria by morphology during confocal analysis. (A)
Maximum projection confocal image of a cell shed from the bladder of a LUTS patient with a mixed sub-threshold infection with E.
faecalis and E. coli. The left image is a composite showing the wheat germ agglutinin (WGA)-stained plasma membrane in magenta
and DAPI stained host and bacterial DNA in green. Solid white arrow highlights a cluster of intracellular coccoid bacteria, broken
white arrow highlights extracellular coccoid bacteria. Bacteria were identified as E. faecalis owing to morphology. Orthogonal views
are through entire Z-stack at a position corresponding to white broken lines on the left image, showing intracellular colonisation. The
centre and right image show the respective DAPI and WGA channels in monochrome. White scale bar is 5µm. (B) A 3-dimensional
volume through the entire Z-stack at a position corresponding to the red squares in image A (numbered for orientation); bacteria are
clearly residing within the cell. (C) A region of bacterial colonisation was selected (highlighted by the white line in 3D construct B)
and used to produce a Z-axis profile plot, which presents the average pixel intensity of a given channel moving through the 80-slice
Z-stack. This graphical representation shows further evidence of cellular invasion, with the peak mean pixel intensity of the DAPI
channel (E. faecalis, green) corresponding with a striking reduction in the WGA (plasma membrane, magenta) channel at slice 29
(̴ centre of the cell). (D) Maximum projection confocal image of a cell shed from the same patient as above with a mixed sub-
threshold infection with E. faecalis and E. coli. Images were analysed and presented as above. Bacteria were identified as E. coli
owing to bacillus morphology. Orthogonal views show the E. coli to be strongly associated with the plasma membrane but entirely
extracellular. White scale bar is 5µm. (E) 3-dimensional volume corresponding to the red squares in image D (numbered for
orientation); again, the E. coli were shown to be ubiquitously extracellular. (F) A region of bacterial colonisation was selected
(highlighted by the white line in 3D construct E) to produce a Z-axis profile plot. This graphical representation shows further
evidence of external cellular colonisation alone. The peak mean pixel intensity of the DAPI channel corresponded with that of the
WGA stained apical plasma membrane channel at slice 21.
doi: 10.1371/journal.pone.0083637.g003
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Figure 4.  3D confocal analysis of cultured cells infected with LUTS-isolated E. coli.  (A) Confocal image of a group of T24
cells infected for 2.5hrs with E. coli isolated from LUTS patients at an MOI of approximately 10-15 bacteria per mammalian cell. The
left image is a composite showing the phalloidin-stained F-actin in red, wheat germ agglutinin (WGA) stained plasma membrane in
green and DAPI stained host and bacterial DNA in blue. The left centre, right centre and far right images show the respective DAPI,
phalloidin and WGA channels in monochrome. Solid white arrows highlight WGA-positive staining of an exopolymeric matrix
secreted by E. coli during biofilm formation. White scale bar is 10µm. (B) A 3-dimensional volume through entire Z-stack at a
position corresponding to the red squares in image A (numbered for orientation); the E. coli is clearly bound to the extracellular
space. (C) A Z-axis profile plot was produced as in Figure 3. The DAPI channel is approximately 16 slices (in the Z-axis) from that of
the phalloidin channel, confirming purely extracellular colonisation. (D) 3D construct of the cells shown in A with the DAPI channel
shown alone. This image shows the extent of bacterial infection. Very deep and tightly packed E. coli biofilms can be seen covering
the apical membrane of the T24 cells. The region of interest analysed in B and C is indicated with a white line.
doi: 10.1371/journal.pone.0083637.g004
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using confocal microscopy and explored extensively with 3D
digital analyses.
Unlike E. coli, E. faecalis adhered to the T24 cells in looser,
more diffuse clusters (See Figure 5 for a representative
example). More organised colonies were evident, although they
manifested close to the T24 nuclei and within the horizontal
boundaries of the cells, which suggested cellular invasion
(Figure 5A). Z-stack 3D constructs of these bacterial colonies
clearly showed all five of the LUTS patient isolated E. faecalis
to be sandwiched within the intracellular space of the T24 cells
(Figure 5B, D). These findings were mirrored in the Z-axis
profile plots, which showed a marked decrease in mean pixel
intensity of phalloidin-labelled F-actin (red) and a striking
increase in the mean pixel intensity of the DAPI labelled E.
faecalis at mid-cell slices (Figure 5C).
Significant bacterial pathology associated with the urothelium
is clearly evident in the LUTS population and the results of
these 3D analyses support the hypothesis of intracellular
colonisation by E. faecalis in LUTS patients. In contrast to the
case of acute infection, it would appear that E. coli may not be
ubiquitously invasive in the context of chronic low-grade UTI. It
is important to note, however, that the lack of invasion may not
necessarily preclude pathogenicity; the ability to form
extracellular biofilms, as E. coli did in this study, could prove
equally challenging to treat.
Discussion
Over the past decade, a model of the pathophysiology of UTI
has solidified into accepted fact. Stemming from the initial
elegant description of intracellular UPEC in mouse models of
acute UTI [23], a number of studies have generally supported
these initial findings. The data in mouse models is indeed
robust [5,21–27]. It is worth noting, however, that the evidence
for the presence of intracellular bacteria in human patients
suffering acute UTI is confined to only one report of 80 women
[24]. Another report has shown that UPEC isolated from
women with acute cystitis were competent to form IBC in mice
[27], but this evidence is not direct proof of their presence in
the original patients. Hence, more data on the pervasiveness of
intracellular bacteria in acute human UTI would be welcome.
In the case of non-acute, low-grade UTI responsible for
chronic lower urinary tract symptoms, such as those exhibited
by the patients in our clinic, even less is known about the
bacterial lifecycle within the bladder. Our previous study
showed that E. coli is not the sole or even foremost pathogen
in these patients, and that a spectrum of species may be
capable of causing such troublesome symptoms [19]. In that
report we showed close association of four bacterial species –
E. faecalis, Streptococcus angiosus, E. coli and Proteus spp.
with epithelial cells shed from patients, suggestive of
intracellular colonization, and further demonstrated that these
bacterial isolates seemed competent to invade a bladder cell
line, as assessed by an antibiotic protection assay. We were
aware, however, that this assay, although widely trusted and
used, could give misleading results if all extracellular bacteria
were not killed by the antibiotics, for example if they were
protected by biofilm formation or by very close association
within niches in the external cell membrane.
Our current efforts improve on these methods. We saw
compelling evidence of intracellular bacteria in patient-isolated
urothelial cells using fluorescence confocal microscopy.
Furthermore, these data strongly suggested E. faecalis was the
invasive pathogen whereas E. coli appeared to be associated
with the surface membrane. Although UPEC at the centre of
IBCs can exhibit a coccoid morphology, these biofilm-like pods
in experimental mouse models are very tightly packed and
UPEC residing at the circumference of this pod, along with
extracellular adherent bacteria, maintain a more rod-shaped (or
filamentous) morphology [5,23,25]. In contrast, in this study,
the colonies observed were far more loosely organised and
both extracellular and intracellular bacteria were equally
coccoid in morphology. We concluded therefore, with
corresponding culture results and phenotypic bacterial typing,
that the invasive pathogen was indeed E. faecalis.
Nevertheless, in future work, species-specific labelling using
molecular methods such as PNA-FISH could be employed for
definitive identification [54]. It will also be important to survey
more patients to see how widespread this phenomenon is.
When isolates of E. coli or E. faecalis were used to infect a
human bladder cell line, which could be fixed post-infection and
examined via confocal microscopy, we detected unequivocal
intracellular colonization by five out of five isolates of E.
faecalis. Surprisingly, although all five E. coli isolates
demonstrated extensive extracellular adherence and biofilm
formation, none were able to invade the cells. It is known that
the bacterial virulence factor FimH is required for E. coli to
invade bladder cells [55], so it is possible that our LUTS-
derived isolates were deficient in some way for expression or
sequence of this domain. However, this is unlikely, as we
confirmed using a standard blood agglutination assay that our
LUTS-derived E. coli expressed functional FimH (data not
shown). Also, FimH is required for extracellular adhesion
[56–58] and pathogenic biofilm formation [59], which all five
strains were able to achieve in our tissue culture experiments.
This suggests that E. coli isolated from these patients are
indeed pathogenic but may lack the necessary downstream
post-adhesion factors required for invasion. Further exploration
of the FimH sequence in these strains and of other virulence
factors could shed light on this interesting difference.
Taken together, these results suggest that, in contrast to the
case of acute UTI, Enterococci may be a key invasive
pathogen in LUTS. The mechanism by which E. faecalis
invades urothelial cells is unknown. However, it is likely that, as
with E. coli invasion, a necessary first step would be adhesion,
in which case various previously described adhesion proteins
are likely to be involved [60]. Afterwards, it is possible that, like
E. coli, E. faecalis may take advantage of the unique fusiform
vesicle trafficking system used by urothelial cells to rapidly
change the tissue surface area, and become passively
engulfed [5]. Alternatively, it is known that E. faecalis are able
to invade intestinal epithelial cells via the production of
aggregation substance (AS) and therefore it is possible that a
similar mechanism is involved in urothelial invasion [61].
Additional studies with more isolates will be needed to see how
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Figure 5.  3D confocal analysis of cultured cells infected with LUTS-isolated E. faecalis.  (A) Confocal image of a group of T24
cells infected for 2.5hrs with E. faecalis isolated from LUTS patients at an MOI of approximately 10-15 bacteria per mammalian cell.
The left image is a composite showing the phalloidin stained F-actin in red, wheat germ agglutinin (WGA)-stained plasma
membrane in green and DAPI stained host and bacterial DNA in blue. The left centre, right centre and far right images show the
respective DAPI, phalloidin and WGA channels in monochrome. White scale bar is 10µm. (B) A 3-dimensional volume through
entire Z-stack at a position corresponding to the red squares in image A (numbered for orientation). This construct shows clear and
extensive invasion and colonisation of the T24 cell by E. faecalis. (C) A Z-axis profile plot was produced as in Figures 3 and 4. The
peak mean pixel intensity of the DAPI channel corresponds with a striking reduction of the phalloidin channel at slice 51 (̴ centre of
the cell), confirming intracellular infection. (D) 3D construct of the entire cell as in Figure 5. This image shows the tightly packed
intracellular biofilm like cluster of E. faecalis in close proximity to the T24 nucleus (white arrow).
doi: 10.1371/journal.pone.0083637.g005
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widespread E. faecalis is in LUTS patients, the invasive
mechanisms involved and whether other species can also
invade. Meanwhile, these data constitute, to our knowledge,
the first report of definitive intracellular invasion of urothelial
cells by E. faecalis.
One of the problems of pinpointing an infective aetiology for
LUTS lies in the poor sensitivity of routine urine testing, whose
weakness has been amply demonstrated [14–16]. Infection
associated with lower counts of bacteria, which may
nevertheless be significant in the case of LUTS patients [19],
tend not to be detected by urinary dipstick for nitrite or
leukocyte esterase, nor by routine MSU cultures with high
thresholds for what is considered “positive” (e.g. in the UK and
many other countries, this breakpoint is ≥105 cfu ml-1).
Therefore, there is much interest in markers that might help
diagnose such lower-grade urinary infections. Pyuria is one
such validated marker. In addition, during acute UPEC-
mediated UTI, inflammatory responses are known to cause
urothelial cell shedding in both mice and humans [24,28–31].
This jettisoning is thought to be a defense mechanism to
reduce bacterial burden in the urothelium. While some have
dismissed urothelial cells in urine as contamination from the
urogenital area during sample collection, our data show that
the vast majority of these cells stain positive for uroplakin-3 and
can therefore be considered to originate from the urothelium. In
our study, epithelial shedding showed a strong relationship with
pyuria: the higher the white blood cell count in the urine, the
more epithelial cells were shed. Interestingly, even low pyuria
counts (1 to 9 WBC µl-1) were associated with shedding,
supporting the hypothesis that examining such cells in fresh
urine, along with pyuria, might help diagnose infection
undetected by dipstick or routine MSU culture.
In mouse models, urothelial shedding has been proposed to
facilitate the deeper invasion of the bladder by allowing access
of bacteria to exposed transitional layers. Quiescent
intracellular reservoirs (QIR) can result, leading to a chronic
and/or recurrent infection situation [5,22,26,31,32]. Data from
human recurrent UTI demonstrate that 68% of bacteriological
recurrence is caused by identical bacterial strains to that of the
index infection [33]. Although it could be argued that these
relapses are caused by reintroduction of pathogen from faecal
flora [3], same-strain infections can occur up to 3 years later
[35] and the application of daily topical antibiotics to the
perineum does not prevent recurrent episodes [34]. Although
QIR have not been directly seen in human patients, these data
are at least suggestive that QIR might play a role in
intransigent LUTS. Further studies are needed to confirm this
hypothesis.
In summary, our data suggest that some LUTS may be
generated by low-grade intracellular infection of the bladder by
E. faecalis. These results therefore may have far-reaching
implications for our diagnosis, treatment and understanding of
the aetiology of LUTS
Materials and Methods
Ethics statement
Ethical committee approval for human urine sampling was
obtained from East Central London REC1 (Research Ethical
Committee). All study participants gave written consent to
participate in the study and the process was documented as
per Good Clinical Practice (GCP) and MHRA guidelines. The
participants were assigned randomly generated study numbers
which were used to anonymise all data and samples. Analysis
was carried out by blinded researchers.
Patient sampling
Sampling was conducted at Professor James Malone-Lee’s
LUTS outpatient clinic, University College London, Division of
Medicine. We sampled from 705 adults aged ≥18 years who
were able to give consent and who were diagnosed with LUTS
(see Figure S1 for a summary of the cohort’s demographics
and symptoms), excluding any patient with symptoms of acute
UTI, with concurrent illnesses that in our opinion were likely to
compromise the validity of the data, and pregnant women or
those planning to conceive. When controls were required, we
recruited with consent from staff that did not have any LUTS.
All laboratory experiments used randomly selected sub-sets of
the main patient cohort. Details can be found in the respective
results sections.
In all cases, subjects were provided with a sterile container
and two hypoallergenic wipes. They were then given detailed
(written and oral) instructions on meticulous MSU capture
technique, namely (1) to wash their hands and thoroughly
cleanse genital area with a hypoallergenic wipe to prevent
contamination from the surrounding external genitalia; (2) to
part labia or retract foreskin and urinate a small amount into the
toilet before moving the container into the urine stream; and (3)
to remove the container before urination was complete,
thereafter to seal the container. The urine sample was divided
into two aliquots. The first was submitted to immediate
microscopy using a haemocytometer to enumerate leukocytes
(WBC μl-1) and shed epithelial cells (EPC μl-1). The second
aliquot, as per standard clinical guidelines, was sent for routine
MSU culture at the Whittington Hospital NHS Trust, London,
UK. The sampled urine was treated fresh, or after overnight
storage at 4°C at the hospital laboratory. 1μl of urine was
transferred by calibrated loop to chromogenic media, CPS3
(bioMerieux). The plate was incubated aerobically for 24 hrs at
37°C. Bacterial colonies were identified at the genus level by
colour change. The result was reported as positive if greater
than 105 (MSU) colony forming units (cfu) ml-1 of a single
known urinary pathogen were observed.
Bacterial identification at the species level
To corroborate confocal data and identify bacteria prior to the
invasion assays, the routine urine procedure above was
repeated in-house with the addition of a dilution series and
extensive phenotypic analyses to confirm bacterial identity at
the species level.
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For each sample, 50μl of undiluted urine and three serial
dilutions (1:10, 1:100 and 1:1000) were added to the respective
quartile of a chromogenic CPS3 agar plate (bioMérieux) before
aerobic incubation for 24 hours at 37°C. Following incubation,
the different coloured colonies present on the chromogenic
agar were identified using the manufacturer’s colour criteria.
The colonies found in this study were identified as follows: E.
coli; medium sized burgundy, pink or mauve colonies and
Enterococcus spp.; small turquoise colonies.
To further confirm the identity as E. coli, the isolates were
shown to be bacillus in morphology and negative under Gram
staining, indole positive and identified as E. coli using API 20E
(bioMérieux) biochemical test strips. Each of the Enterococcus
spp. tested in this study were found to be E. faecalis owing to a
coccoid morphology, positive Gram stain, negative catalase
test, positive bile esculin test and by being identified as E.
faecalis using API 20 Strep (bioMérieux) biochemical test
strips.
Cell culture
A transformed cell line derived from a human bladder
carcinoma (T24) [62] was kindly donated by Dr. Aled Clayton,
Institute of Cancer and Genetics, School of Medicine, Cardiff
University, United Kingdom. T24 cells were cultured at 37°C in
a humidified incubator under 5% CO2 in 9 cm dishes in RPMI
1640 medium (Gibco) supplemented with 10% fetal bovine
serum (FBS, PAA) and antibiotics (50 µg/ml penicillin and 50
mg/ml streptomycin; Gibco). Cells were maintained, pre-
experimentation, by splitting 1:20 at 80% confluency. All work
was carried out within sterile class-II flow cabinets under strict
aseptic conditions.
Immunofluorescence staining of patient samples
80µl of a urine specimen was added to a Shandon single
funnel cuvette assembly containing a pre-labeled glass slide
and a Shandon filter card (Fisher Scientific). This assembly
was centrifuged in a Shandon Cytospin 2 cytocentrifuge at
800rpm (≈75g rcf) for 5 minutes resulting in a visible disc of
urinary particulate deposited on the slide, which was
circumscribed with a hydrophobic barrier pen (ImmEdge pen,
Vector Laboratories). The cells were fixed in 4% formaldehyde
(Thermo Scientific, Fisher Scientific) in phosphate buffered
saline (PBS, Sigma-Aldrich) at RT for 15 minutes. The
formaldehyde was aspirated and the preparation washed three
times with PBS at 5 minute intervals. For uroplakin-III staining,
cells were permeabilised with 0.2% Triton-X100 (Sigma-
Aldrich) in PBS for 5 minutes at RT followed by a single wash
with PBS. The preparation was then blocked with 5% normal
goat serum (Sigma-Aldrich) in PBS for 30 minutes prior to a 1
hour incubation with a 1:10 dilution of primary anti-uroplakin-III
mouse monoclonal antibody (Progen Bioteknik) in 1% bovine
serum albumin (BSA, Sigma-Aldrich). Following 3 further PBS
washes, cells were incubated at RT for 40 minutes in a solution
containing a 1:250 dilution of goat anti-mouse secondary
antibody conjugated to Alexa Fluor-555 (Invitrogen), 1μg/μl of
the DNA counterstain 4’’,6-diamidino-2-phenylindole, (DAPI,
Sigma-Aldrich) and 1% BSA in PBS.
For assessing bacterial infection, after fixation as above,
wheat germ agglutinin (WGA) conjugated to Alexa Fluor-488
(Invitrogen) was used to label the cell membrane to aid cellular
identification and demarcation, and to assess biofilm formation
where applicable. Following 15 minutes of incubation at RT
with 1µg/ml WGA in Hank’s balanced salt solution minus
phenol red (HBSS, Invitrogen), the labeling solution was
removed and the cells washed twice at 5 minute intervals with
HBSS. Fluorescent counterstaining of host and pathogen DNA
was achieved through the addition of DAPI at 1µg/ml in PBS.
After incubation for 15 minutes at RT, the DAPI solution was
removed and the sediment washed twice in PBS. Following
staining for uroplakin-III or infection, the preparations were
immediately mounted with FluorSave reagent (Calbiochem)
and a coverslip fixed in place with clear nail varnish. The
percentage of UP3-positive cells was calculated by a blinded
researcher using epi-fluorescent microscopy. Counts were
carried out in triplicate. Images were also taken using scanning
confocal microscopy on a Leica SP5.
Invasion assay
5 frozen Enterococcus faecalis and 5 frozen Escherichia coli
strains previously isolated and typed from human LUTS
patients were grown on fresh chromogenic CPS3 agar plates.
After aerobic incubation for 24 hours at 37°C, a colony from
each of these 2 bacterial cultures was transferred to a 5ml
sterile aliquot of LB, and incubated aerobically at 37°C for 24
hours. Two of the 5 E. coli isolates underwent stationary
incubation and the remaining 3 shaking incubation at 300rpm
to control for FimH expression in these strains, as stationary
growth has been reported to promote expression of this
virulence factor [55]. In our hands, the two different methods of
culture produced similar functional FimH behaviour. E. faecalis
isolates were all incubated in a shaking incubator at 300rpm.
The level of growth was checked for each bacteria using a
spectrophotometer and diluted as necessary with fresh LB to
an A600 of approximately 0.5 [63]. Lab-Tek II 8 well chamber
slides (Nunc, Thermo Scientific) were coated with 200µl of FBS
and incubated for 2 hours at 37°C before aspiration. T24 cells
were plated at 8x104 cells per well in a total volume of 400 µL
and incubated for 24 hours at 37°C under 5% CO2 to allow
cells to spread, then washed twice with PBS to remove routine
antibiotics. Each of the bacterial LB cultures was diluted in
CO2-independent media (CIM, Gibco) supplemented with 10%
FBS (with routine antibiotics omitted) and 200µl added to the
cultured T24 cells giving a multiplicity of infection (MOI) of
approximately 10-15 bacteria per mammalian cell [63]. Cells
were infected at 37°C for between 1 and 4 hours within a
humidified aerobic incubator to optimise experimental
parameters.
Post infection, cells were inspected for morphological
changes and viability before the addition of a combination of
membrane-impermeable antibiotics to kill extracellular bacteria
and to limit further cellular damage [19,38,39,63]. Briefly,
infected CIM was carefully removed and a solution of
gentamicin, linezolid and amoxycillin (Whittington Health NHS
Trust Pharmacy, London) in 200µl fresh CIM was added at
varying concentrations. Concentrations of gentamicin (200µg/
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ml), linezolid (25µg/ml) and amoxycillin (250µg/ml) were found
to be most effective (adapted from [19]). The chamber slide
was incubated, with antibiotics, aerobically for a further 24
hours at 37°C, after which the cells were fixed in 4%
formaldehyde in PBS for 15 min at room temperature before
washing three times in PBS at 5 minute intervals. The cell
membranes were stained with 200µl WGA (1µg/ml) conjugated
to Alexa Fluor-488 in HBSS minus phenol red for 15 min at RT.
The labelling solution was removed and the cells washed twice
at 5 minute intervals with HBSS. 0.2% Triton-X100 in PBS was
then added and the cells allowed to incubate at room
temperature for 5 min. Following removal of the Triton-X100,
the permeabilised cells were washed once with PBS before
staining with a 200µl solution of TRITC-conjugated phalloidin
(0.6µg/ml)(Sigma-Aldrich), to label filamentous actin, and DAPI
(1µg/ml) in PBS for 40 min at RT. The dual-labelling solution
was gently aspirated and the cells washed 3 times in PBS
before removal of the upper-well section of the Lab-Tek II
chamber slide and immediate mounting as above.
Imaging and analysis
We performed epi-fluorescent microscopy on a Olympus
CX-41 and Leica DM4000B upright microscope, and confocal
laser scanning microscopy on a Leica SP5 microscope. Images
were processed and analysed using Infinity Capture and
Analyze V6.2.0, ImageJ 1.46r and the Leica Application Suite,
Advanced Fluorescence 3.1.0 build 8587 Software.
Supporting Information
Figure S1.  Demographics and symptoms. (A) Key
demographic information. (B) A four-way Venn diagram
illustrating the overlap of symptoms amongst the 705 patients
studied. The ellipses circumscribe patients who had one or
more symptoms in the particular subset. Each ellipse
corresponds to a numbered list of specific symptoms. The
diagram is not scaled to the size of sets. Abbreviations; MSU
(mid-stream urine culture); Pyuria (presence of white blood
cells in the urine); WBC (white blood cell); inc (incontinence);
LUTS (lower urinary tract symptoms); OAB (overactive
bladder).
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